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Profile of effective donors from organ and tissue 
procurement services
ORIGINAL ARTICLE
INTRODUCTION
In the area of transplantation, Brazil is notable for having one of the largest 
public organ and tissue transplant programs in the world, currently ranked 
second in kidney, liver and cornea transplants according to absolute numbers.(1) 
Thus, despite the advances in transplantation and the fact that Brazil has a 
systematic and legal protocol for diagnosing brain death (BD),(2) there is still a 
growing imbalance between the supply and demand for organs.(3,4)
Among potential brain-dead organ donors, there are several reasons for not 
harvesting the organs for donation,(5) of which cardiac arrest (CA) is the second 
leading reason for not harvesting organs for donation in 2012, reaching 52% 
in some regions.(6)
To increase the number of brain-dead organ and tissue donors, it is vital that 
the occurrence of CA be reduced by employing strategies aimed at maintaining 
the physiological stability of the patient, thus achieving the maximum vitality 
of potentially transplantable organs.
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Objective: To characterize the profile 
of effective organ and tissue donors and to 
understand which organs and tissues were 
donated for transplantation.
Methods: This was a quantitative, 
descriptive, exploratory, retrospective 
study that analyzed clinical data from 305 
donors between January 2006 to December 
2010. The data were then analyzed using 
descriptive analyses, generating frequency 
tables, measures of position (mean, 
minimum and maximum) and measures of 
dispersion (standard deviation) for data that 
was social and clinical in nature.
Results: There was an overall 
predominance of white (72%) and male 
(55%) individuals between the ages of 41 
and 60 years (44%). The primary cause of 
brain death was cerebrovascular accident 
(55%). In the patient history, 31% of the 
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patients were classified as overweight, 27% 
as hypertensive and only 4.3% as having 
diabetes mellitus. Vasoactive drugs were 
used in 92.7% of the donors, and the main 
drug of choice was noradrenaline (81.6%). 
Hyperglycemia and hypernatremia were 
diagnosed in 78% and 71% of the donors, 
respectively.
Conclusion: Significant hemodynamic 
changes were found, and the results indicate 
that the use of vasoactive drugs was the 
main strategy used to control these changes. 
Furthermore, most donors presented with 
hyperglycemia and hypernatremia, which 
were frequently reported in association with 
brain death. The persistent nature of these 
findings suggests that the organ donors 
were inadequately maintained.
DOI: 10.5935/0103-507X.20140004
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Maintaining the potential brain-dead donor requires 
the dedication and technical expertise of the team 
responsible for patient care because, during BD, a series 
of physiological changes occur that contribute to the 
instability of the patient, which may result in hypotension, 
diabetes insipidus, hypothermia, hypernatremia, metabolic 
acidosis, pulmonary edema and disseminated intravascular 
coagulation,(5,6) in addition to hyperglycemia, which can 
be explained by the combination of elevated endogenous 
catecholamines, exogenous inotropic agents and steroids, 
which are further aggravated by the administration of 
glycosylated substances.(7)
These physiological changes may occur secondary 
to patient treatment, neurological damage or as a result 
of physiological changes resulting from BD.(8) When 
these changes are present in a potential donor, they can 
contribute to CA.
Although organ and tissue transplantation is a safe 
and effective therapeutic alternative in the treatment of 
various diseases, resulting in improved quality of life and 
increased likelihood of survival,(6) there is a race against 
time to turn a potential donor, with all the hemodynamic/
physiological instability that BD causes, into an effective 
donor that can offer recipients the highest quality organs. 
Thus, there is a need to know the functional status of the 
organs that are removed for transplantation and to adopt 
corrective strategies in response to possible changes. 
This study therefore aimed to characterize the profile of 
effective organ and tissue donors.
METHODS
This was a quantitative, descriptive, exploratory and 
retrospective study.(9) The research was conducted at the 
Organ and Tissue Procurement Service of the Hospital 
de Clínicas da Universidade Estadual de Campinas 
(UNICAMP), located in the city of Campinas, São Paulo 
(SP), Brazil. This service is responsible for the notification 
and implementation of donations in all the hospitals 
in the administrative region of Campinas. The study 
was approved by the Research Ethics Committee of the 
Faculdade de Ciências Médicas, UNICAMP (Opinion 
Nº 1163/2011), which granted a waiver for the informed 
consent requirement.
The study population consisted of patients whose data 
were contained in the "Information About Multiple Organ 
Donor" records of the Organ and Tissue Procurement 
Services (potential deceased donors who were brain dead) 
and who underwent surgery to remove the organs (effective 
donor) with the approval of the Organ Notification, 
Procurement and Distribution Center of the municipality 
of Ribeirão Preto.
The patient records that were reviewed and analyzed 
were from the period between January 2006 and December 
2010. They contained all the information necessary to meet 
the inclusion and exclusion criteria of the study protocol. 
Data collection was performed between December 2011 
and January 2012.
The inclusion criteria were that the data contained in 
the record showed that patients were effective donors, i.e., 
the extraction surgery was performed. These patients were 
identified by records showing that the extracted organs were 
subsequently implanted or discarded for transplantation 
(when sent for pathological examinations).
The exclusion criteria included prospective donors 
who were not effective donors, i.e., who did not undergo 
surgical removal of organs, and living organ donors, 
understood here as related (relatives up to the fourth 
degree) or unrelated (no relation) donors.
The principal investigator performed the data collection 
on the premises of the Organ and Tissue Procurement 
Services.
The data on the effective donors were recovered using 
records on Multiple Organ Donors prepared by the State 
Department of Health/State Transplant System (records 
available at the Organ and Tissue Procurement Services) 
and then entered into a spreadsheet prepared especially 
for this study. The following information was recorded: 
gender, age range, race, cause of BD, comorbidities 
(hypertension - HTN, diabetes mellitus - DM in the 
donor or in first-degree relatives - DFDR), obesity, 
habits (tobacco use, drug addiction and alcoholism), 
mean arterial pressure (MAP) levels, amount and type 
of vasoactive drugs (DVA) used, serum levels of urea, 
creatinine, sodium, potassium and glucose and the organs 
and tissues donated.
The data were transferred to the program Excel for 
Windows/2003 and then to the program Statistical 
Analysis System (SAS) for Windows, version 8.02, for 
the descriptive analyses and to calculate frequency tables, 
measures of position (mean, minimum and maximum) 
and measures of dispersion (standard deviation) for data 
that were social and clinical in nature.
The reference values used in adults, which were 
established by the pathology laboratory at the Hospital de 
Clínicas of the UNICAMP where the blood samples were 
processed, were serum urea (<58mg/dL), creatinine (male 
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up to 1.2mg/dL and female up to 0.9mg/dl), sodium 
(136 to 146mEq/L), potassium (3.1 to 5.4mEq/L) and 
glucose (60 to 100mg/dL). The discrimination criteria for 
being overweight (body mass index - BMI≥25) or obese 
(BMI≥30) were based on the classification defined by the 
World Health Organization.(10)
RESULTS
The Organ and Tissue Procurement Services of the 
Hospital de Clínicas of the UNICAMP, from January 2006 
to December 2010, provided 305 effective donors for the 
State Transplantation System of São Paulo.
The majority of the effective donors were male (n=167, 
55%) and Caucasian (n=220, 72%), with a mean age of 
41.45±14.1 years (ranging from 1.5 years to 81 years), as 
shown in table 1.
Figure 1 shows that 44% (n=135) of the donors 
evaluated by the Organ and Tissue Procurement Services 
of the Hospital de Clínicas of the UNICAMP were in the 
41-60 year age group.
Among the primary causes of BD in effective donors 
evaluated, cerebrovascular accident (CVA) was the most 
predominant, responsible for more than half of all cases 
of BD (55%), followed by traumatic brain injury (TBI) at 
35% and "other", which accounted for a total of 10% of 
the cases of BD, including central nervous system tumors, 
hypoxicischaemic encephalopathy, firearm injuries and 
hydrocephalus.
Of the history and lifestyle habits of the donors 
(Table 1), being overweight (31.15%) and hypertensive 
(27.0%) stood out. Among the lifestyle habits, tobacco 
use or alcohol consumption were found in approximately 
20% of the donors.
For hemodynamic maintenance, ventricular assist 
devices (VADs) were used in 92.7% (n=283) of the 
donors, of which noradrenaline was the main drug of 
choice (n=249, 81.6%) and vasopressin the secondary 
drug of choice (n=2, 0.65%) (Table 1). The mean MAP 
levels were 88.02±17.02mmHg (ranging from 49 to 
136.66mmHg).
According to table 1, the renal function evaluation 
of potential organ and tissue donors revealed an average 
creatinine level of 0.93±0.11mg/dL (ranging from 0.05 to 
6.7mg/dL). For urea, the mean level was 47.0±29.3mg/dL 
(ranging from 10 to 221mg/dL). Values that were higher 
than the accepted reference values for serum creatinine 
levels were observed in 159 (52.1%) effective donors, 89 
(29.2%) of whom had creatinine values >1.5mg/dL, and 
of these, 77 (25.3%) were kidney donors.
Table 1 - Descriptive, clinical, hemodynamic characterization and renal and 
electrolyte profiles of effective donors
Variable Result (N=305)
Age (years) 41.45±14.1
Race
Caucasian 220 (72.0)
Black 28 (9.0)
Asian 3 (0.9)
Pardo (mixed race) 54 (17.0)
Male 167 (55)
History
Overweight 95 (31.15)
HTN 82 (27.0)
DFDR 42 (14.0)
Obesity 23 (7.55)
DM 13 (4.3)
Habits
Tobacco use 60 (19.7)
Alcoholism 57 (18.7)
Drug addiction 27 (8.8)
Hemodynamics
VAG 283 (92.7)
Noradrenaline 249 (81.6)
Dose (mcg/kg/min) 0.21 (0.001-3.25)
Dopamine 73 (24.0)
Dose (mcg/kg/min) 7 (0.1-20.0)
Dobutamine 9 (3.0)
Dose (mcg/kg/min) 7.5 (4.0-10.0)
Vasopressin 2 (0.65)
Dose (U/min) 0.44 (0.4-0.48)
Renal profile
Creatinine (mg/dL) 0.93±0.11
Urea (mg/dL) 47±29.3
Electrolyte profile
Sodium (mEq/L) 160.42±16.1
Potassium (mEq/L) 3.33±1.0
Glucose (mg/dL) 162.5±86.0
HTN - hypertension; DFDR - first-degree relatives with diabetes mellitus, DM - diabetes 
mellitus; VAG - vasoactive drugs. Results are expressed as number (percentage), 
mean±standard deviation or median (minimum–maximum).
For the electrolyte profile, the mean serum sodium 
level was 160.42±16.1mEq/L (127 to 203mEq/L), and 
the mean potassium level was 3.33±1.0mEq/L (1.4 to 
7.8mEq/L). In 189 (62%) donors, the serum sodium 
levels were greater than 155mEq/L, and of these, the liver 
was harvested from 162 (53.1%) donors.
The average blood glucose level was 162.5±86.0mg/dL 
(55 to 586mg/dL), and hyperglycemia was observed in 
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Studies performed in Brazil(11,12) and abroad(13,14) are 
consistent with the present study, i.e., the age range of 
approximately 50% of the donors was between 41 and 
60 years.
Of the primary causes of BD among organ and tissue 
donors, CVA was the most prevalent, which is consistent 
with reports by other researchers.(11-15) In the present 
study, TBI was the second leading cause, and this finding 
is confirmed in the literature.(11,13,15) These data indicate a 
change in the profile of organ donors because traumatic 
causes are being supplanted by CVA as the cause of death. 
This change may be related to stricter traffic regulations 
in Brazil, which have reduced the number of automotive 
accidents and increased the life expectancy of Brazilians.
Researchers have shown direct correlations between 
CVA and cardiovascular diseases with obesity, hypertension, 
diabetes, tobacco use and alcoholism.(16,17) In recent 
decades, the number of obese donors has been increasing, 
and complications following renal transplantation have 
been correlated with being overweight and obese.(13)
As we observed in this study for donors with these 
comorbidities and potentially health-compromising 
social habits, the quality of the graft is expected to be 
worse because of the dysfunctional organic processes that 
characterize these diseases.
Donors with such risk factors are referred to as 
"marginal", "borderline" or "expanded criteria" donors, 
and these donations have been legalized by laws governing 
transplantation due to the small number of organs 
available for transplantation in Brazil.(18)
The use of organs from "marginal" donors may increase 
the chances of transplant failure. One study reported an 
increase in mortality in liver transplant patients, especially 
in cases in which the recipients were more seriously ill.(19)
Due to the shortage of organs and the number of 
people needing a transplant, it is extremely important 
that potential donors are well cared for by trained 
professionals, minimizing important endocrine, metabolic 
and hemodynamic disturbances caused by BD.
Hemodynamic maintenance is the main challenge 
in treating potential donors because following the 
adrenergic storm, hypotension is observed, which is a 
common problem that leads to decreased perfusion of 
various organs,(20) requiring the pressure parameters to 
be corrected fairly quickly. Experts recommend that the 
achievable blood pressure goals should be a MAP between 
60 and 80mmHg and a systolic BP ranging from 90 to 
100mmHg.(21-24)
78.4% of the donors evaluated. In 29.2% (n=89) of the 
donors, the blood glucose value was higher than 180mg/dL. 
Hypernatremia was observed in 77.7% (n=237) of the 
donors, and hypokalemia was observed in 15.0% (n=46).
All the donors with expanded criteria had at least 
one organ harvested. Among the 14 donors more than 
60 years of age, 12 were liver donors and 14 were kidney 
donors. Of the donors between the ages of 50 and 59 years 
with prior HTN and who had a CVA as the cause of coma 
(n=36), 29 of them were liver donors and 34 were kidney 
donors. Among the obese donors (n=23), there were 18 
liver donors, 16 kidney donors, three heart donors and 
three pancreas donors.
In total, 92.7% (n=283) of the donors had their kidney 
harvested, 87.8% (n=268) their liver, 79.0% (n=241) their 
corneas, 23.3% (n=71) their pancreas, 11.5% (n=35) their 
bones, 11.1% (n=34) their hearts and only 6% (n=18) 
their lungs.
DISCUSSION
In the present study, the major comorbidities observed 
in organ and tissue donors from the Organ and Tissue 
Procurement Services of the Hospital de Clínicas of the 
UNICAMP included being overweight and hypertensive. 
For pressure stability, noradrenaline was the drug of choice, 
and vasopressin was used the least often. Hyperglycemia and 
hypernatremia were the most frequent metabolic disorders, 
representing, in part, the likely failure to maintain potential 
donors. The serum creatinine levels were greater than the 
reference values in more than 50% of the donors, and of those 
with creatinine levels >1.5mg/dL (89, 29.2%), 77 (25.3%) 
were kidney donors. At least one organ was harvested in 100% 
of the donors who were considered "marginal". The kidneys 
were harvested the most frequently compared to other organs, 
such as the liver, pancreas, heart and lungs. The corneas were 
the tissue harvested most frequently for transplantation.
Figure 1 - Distribution of organ and tissue donors according to age range.
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To ensure adequate perfusion, vasopressor and 
inotropic support should be provided if the minimum 
BP is not reached or maintained after adequate volume 
expansion. Vasopressor and/or inotropic drugs should 
then be given with caution because the overuse of these 
drugs can lead to severe vasoconstriction followed by 
ischemia of the organs.(23,24) The administration (more 
restrictive) of fluids for fluid replacement in maintaining 
the potential donor has resulted in an increased number of 
successful lung transplants.(5,16)
In the present study, the analysis of the mean blood 
pressure values (MAP 88.02±17.02 mmHg, ranging 
from 49 to 136.66mmHg) and VAD use in a large 
number of donors (92.7%) indicates that the use of 
vasopressor drugs in potential donors may have been 
excessive and/or indiscriminate, given that most of 
the MAP values in this study were higher than those 
recommended in the literature.
One strategy by which to improve hemodynamic 
maintenance in potential deceased donors involves 
hormone replacement therapy, with the administration 
of vasopressin, thyroid hormones and corticosteroids.(25) 
In this study, the use of vasopressin was limited (only 
administered to two donors, 0.65%), which can be 
explained by the fact that the donor sample consisted 
of organ and tissue donors from the period between 
2006 and 2010, which is well before the "Guidelines 
for the Handling of Multiple Organs from Potential 
Adult Deceased Donors" was available to the Brazilian 
scientific community.
The use of managed treatment protocols for potential 
deceased donors helps improve the hemodynamic and 
physiological maintenance of these patients by reducing 
the incidence of CA before harvesting the organs, which 
may contribute to an increase in the supply of organs 
and tissues.(26)
In the analysis of the renal profile, the mean creatinine 
and urea levels, as shown in table 1, were found to be 
comparable to those reported by Weissenbacher et al.(13) in 
a sample of 1,113 deceased kidney donors.
A study indicates that changes in glucose levels, if not 
corrected, affect the renal function of donors.(27) Olmos 
et al.(28) reported significant correlations between donors 
undergoing procedures to correct blood glucose levels and 
improved renal function.
Blasi-Ibañez et al.(29) evaluated 458 organ donors and 
showed a strong correlation between blood glucose and 
serum creatinine levels immediately before nephrectomy, 
reporting blood glucose levels >200mg/dL in 72% of 
the donors at the time of organ harvesting. However, 
these findings are somewhat controversial because there 
is only a limited number of studies that have performed 
correlation analyses with these variables in brain-dead 
patients. In addition, in a study conducted using intensive 
care patients, there was an increase in mortality reported 
for patients who were maintained at normoglycemia.(25,30)
In maintaining potential organ donors, experts 
recommend that hyperglycemia be corrected using 
intravenous insulin therapy to achieve blood glucose levels 
of <180mg/dL.(25,26) In an American study that compared 
blood glucose levels in deceased organ donors and the 
use of glycemic control protocols during the period from 
2005 to 2006 (donors not receiving the glycemic control 
protocols) and the period from 2009 to 2010 (donors 
receiving the glycemic control protocols), the reported 
averages were 212±32 and 162±44mg/dL, respectively.(28) 
The high blood glucose values observed in the present 
study (162.5±86.0mg/dL, 55 to 586mg/dL) suggest the 
lack of or ineffectiveness of the protocols for glycemic 
control in caring for potential donors.
As for hypernatremia, sodium levels >155mEq/L 
may contribute to edema, dysfunction, apoptosis and 
cellular necrosis. These complications contribute to 
primary graft failure, with the worst results evident in 
liver transplants.(7,30) The analysis of heart donors showed 
an increase in the mortality of recipients when the serum 
sodium levels were <130mEq/L or >170mEq/L.(18) The 
data collected in this study, in which the mean serum 
sodium level was 160.42±16.1mEq/L (ranging from 127 
to 203mEq/L), showed that disorders of this electrolyte, 
coupled with other metabolic abnormalities, put at risk 
the quality of the organs that were extracted from the 
donors at the Organ and Tissue Procurement Services of 
the Hospital de Clínicas of the UNICAMP.
Understanding these changes in potential donors, 
as well as factors that reduce the quality of the graft 
supplied for transplantation such as age, tobacco use, 
history of alcoholism, cause of BD, cold ischemia time 
(time that the organ is outside the donor's body and 
under refrigeration) >12 hours and warm ischemia time 
(time between the onset of the anastomosis of the vena 
cava and portal vein reperfusion in liver recipients) 
>45 minutes,(31) should help doctors anticipate major 
complications in transplant patients.
As noted in this study, the primary harvested organ was 
the kidney (in 92.7% of effective donors). This fact can 
be explained by certain advantages that the kidneys have 
over other solid organs that are harvested: a prolonged 
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cold ischemia time of up to 36 hours,(32,33) acceptable 
donor age of 75 years, provided that renal function is 
preserved and the presence of two organs (some changes 
observed by the surgeon at the time of the nephrectomy 
can lead to discarding only one kidney). Moraes et al.(11) 
reported similar results to those observed in this study, 
including that 81% of their patients were kidney donors 
and only 2% were lung donors. These numbers are 
typical worldwide.(34) For tissue donations, corneas were 
the primary tissue harvested (79%), which can also be 
explained by the advantages that this tissue has over other 
tissues, including that it is not limited by age or the blood 
type of the potential donor and that it can be harvest up 
to 24 hours later if the body of the donor is maintained at 
the appropriate temperature (4°C).(31)
Therefore, this study detected the harvest of organs and 
tissues from donors with expanded criteria and identified 
flaws in the hemodynamic and physiological maintenance 
of these patients. The limitations of the study included that 
it was not possible to analyze the function of these organs 
following explantation (either the transplanted organs or 
those sent for pathology) or to identify the actions taken 
by the care teams concerning the observed changes.
We suggest that correlation studies be performed to 
verify the function of these grafts and the quality of life of 
the transplant patients and to analyze the primary changes 
that led to the discarding of the graft.
CONCLUSION
When considering the clinical profile of effective donors, 
being overweight and hypertensive were the most common 
comorbidities observed. Notably, most of the patients had 
altered serum levels of glucose, sodium and creatinine. 
Hemodynamic instability occurred in the majority of the 
subjects, and the use of noradrenaline as a vasopressor drug 
was observed in almost all cases. Finally, among the "marginal" 
donors, 100% had at least one organ harvested. The kidneys 
were the organ that was harvested the most often for transplant, 
followed by the liver, pancreas, heart, lungs and corneas.
Objetivo: Caracterizar o perfil dos doadores efetivos de órgãos 
e tecidos além de conhecer quais órgãos e tecidos foram doados 
para transplantes.
Métodos: Estudo quantitativo, descritivo, exploratório e 
retrospectivo, analisando-se os dados de prontuários de 305 
doadores, entre janeiro de 2006 a dezembro de 2010, os quais 
foram submetidos à análise descritiva com confecção de tabelas 
de frequência, medidas de posição (média, mínimo e máximo) e 
dispersão (desvio-padrão) para os dados de caráter social e clínico.
Resultados: Houve predomínio de indivíduos brancos 
(72%), do gênero masculino (55%), idade entre 41 e 60 anos 
(44%), sendo a principal causa de morte encefálica o acidente 
vascular encefálico (55%). Quanto aos antecedentes, 31% foram 
classificados na categoria de sobrepeso, seguidos de hipertensão 
arterial sistêmica (27%) e o diabetes mellitus encontrado em 
apenas 4,3% dos doadores. O uso de drogas vasoativas esteve 
presente em 92,7% dos doadores, e a principal droga utilizada foi 
a noradrenalina (81,6%). A hiperglicemia e a hipernatremia foram 
encontradas em 78% e em 71% dos doadores, respectivamente.
Conclusão: Foram encontradas importantes alterações 
hemodinâmicas, e os resultados mostram o uso de drogas vasoativas 
como a principal estratégia para seu controle. Ademais, a maioria 
dos doadores apresentou hiperglicemia e hipernatremia, achados 
frequentes no quadro de morte encefálica, e que, por sua persistência, 
sugerem manutenção inadequada do doador de órgãos.
RESUMO
Descritores: Morte encefálica; Transplante de órgãos; 
Doadores de tecidos; Unidades de terapia intensiva
REFERENCES
  1. Dimensionamento dos transplantes no Brasil e em cada estado (2005-2012). 
Registro Brasileiro de Transplantes. 2012;18(4). [acesso em 09 Setembro 
2013]. Disponível em: http://www.abto.org.br/abtov03/Upload/file/RBT/2012/
RBTdimensionamento2012.pdf
  2. Morato EG. Morte encefálica: conceitos essenciais, diagnóstico e 
atualização. Rev Med Minas Gerais. 2009;19(3):227-36.
  3. Brasil. Secretaria de Estado da Saúde de São Paulo. Sistema Estadual de 
Transplantes. Lista de espera por órgão e córnea - 2010. Lista de espera 
para transplante, com doador cadavérico, no Estado de São Paulo. São 
Paulo: Secretaria de Estado da Saúde de São Paulo, 2010. [citado 2011 
Ago 5]. Disponível em: http://www.saude.sp.gov.br/ses/perfil/gestor/
informacoes-de-saude_1/transplantesem-dados/lista-de-espera-por-
orgao-e-cornea-2012
  4. United States of America. Organ Procurement and Transplantation 
Network. Data. Waiting list candidates 2014. [cited 2014 Jan 21]. 
Disponível em: http://optn.transplant.hrsa.gov/
27 Rodrigues SL, Ferraz Neto JB, Sardinha LA, Araujo S, Zambelli HJ, Boin IF, Athayde MV, Montone EB, Panunto MR
Rev Bras Ter Intensiva. 2014;26(1):21-27
  5. Shah VR. Aggressive management of multiorgan donor. Transplant Proc. 
2008;40(4):1087-90.
  6. Mascia L, Mastromauro I, Viberti S, Vincenzi M, Zanello M. Management 
to optimize organ procurement in brain dead donors. Minerva Anestesiol. 
2008;74:1-8.
  7. M Smith, H Vyas. Management of the potential organ donor. Paediatr Child 
Health (Oxford). 2011;21(4):182-6.
  8. Shemie SD, Ross H, Pagliarello J, Baker AJ, Greig PD, Brand T, Cockfield 
S, Keshavjee S, Nickerson P, Rao V, Guest C, Young K, Doig C; Pediatric 
Recommendations Group. Organ donor management in Canada: 
recommendations of the forum on Medical Management to Optimize 
Donor Organ Potential. CMAJ. 2006;174(6):S13-32.
  9. Gil AC. Como elaborar projeto de pesquisa. 4ª ed. São Paulo: Atlas; 2002.
 10. World Health Organization. Obesity and overweight. WHO; Updated 
March 2013. Fact sheet nº 311; Updated March 2013. [cited 2013 Set 3]. 
http://www.who.int/mediacentre/factsheets/fs311/en/
 11. Moraes EL, Silva LB, Moraes TC, Paixão NC, Izumi NM, Guarino AJ. 
The profile of potential organ and tissue donors. Rev Latinoam Enferm. 
2009;17(5):716-20.
 12. Medina-Pestana JO, Sampaio EM, Santos TH, Aoqui CM, Ammirati AL, 
Caron D, et al. Deceased organ donation in Brazil: how can we improve? 
Transplant Proc. 2007;39(2):401-2.
 13. Weissenbacher A, Jara M, Ulmer H, Biebl M, Bösmüller C, Schneeberger 
S, et al. Recipient and donor body mass index as important risk factors for 
delayed kidney graft function. Transplantation. 2012;93(5):524-9.
 14. Jeong JC, Kim MG, Ro H, Kim YJ, Park HC, Kwon HY, et al. Outcomes 
of management for potential deceased donors. Transplant Proc. 
2012;44(4):843-7.
 15. Silva V, Formaggio P, Oliveira PC, Schaff C, Formigoni TH, Santos XCM. 
Profile of organs and tissue donors and their relatives of a Brazilian Organ 
Procurement Organization. In: 11th Congress of the International Society 
for Organ Donation and Procurement, 2nd Congress of the Iberoamerican 
Society of Transplant Coordinators; 2011 Nov 27-30; Buenos Aires, 
Argentina. Buenos Aires: ISODP; 2011. p. 176.
 16. World Health Organization (WHO). Cardiovascular diseases (CVDs) - What 
are the risk factors for cardiovascular disease? Geneva: WHO; Updated 
March 2013. [cited 2013 May 25]. Available from: http://www.who.int/
mediacentre/factsheets/fs317/en/
 17. World Health Organization (WHO). What are the health consequences of 
being overweight? Geneva: WHO; Updated December 2011. [cited 2012 
Feb 4 ]. Available from: http://www.who.int/features/qa/49/en/index.html.
 18. McKeown DW, Bonser RS, Kellum JA. Management of the heart beating 
brain-dead organ donor. Br J Anaesth. 2012;108(Suppl 1):i96-107.
 19. Bacchella T, Gavão FH, Jesus de Almeida JL, Figueira ER, de Moraes 
A, César Machado MC. Marginal grafts increase early mortality in liver 
transplantation. Sao Paulo Med J. 2008;126(3):161-5.
 20. Dictus C, Vienenkoetter B, Esmaeilzadeh M, Unterberg A, Ahmadi R. 
Critical care management of potential organ donors: our current standard. 
Clin Transplant. 2009;23 Suppl 21:2-9. Review.
 21. Murugan R, Venkataraman R, Wahed AS, Elder M, Carter M, Madden NJ, 
Kellum JA; HIDonOR Study Investigators. HIDonOR Study Investigators. 
Preload responsiveness is associated with increased interleukin-6 and lower 
organ yield from brain-dead donor. Crit Care Med. 2009;37(8):2387-93.
 22. Frontera JA, Kalb T. How I manage the adult potential organ donor: donation 
after neurological death (part 1). Neurocrit Care. 2010;12(1):103-10.
 23. Mascia LI, Mastromauro I, Viberti S, Vincenzi M, Zanello M. Management 
to optimize organ procurement in brain death donors. Minerva Anestesiol. 
2009; 75(3):125-33.
 24. Westphal GA, Caldeira Filho M, Vieira KD, Zaclikevis VR, Bartz MC, 
Wanzuita R, et al. Diretrizes para manutenção de múltiplos órgãos no 
potencial doador adulto falecido. Parte I. Aspectos gerais e suporte 
hemodinâmico. Rev Bras Ter Intensiva. 2011;23(3):255-68.
 25. Westphal GA, Caldeira Filho M, Vieira KD, Zaclikevis VR, Bartz MC, 
Wanzuita R, et al. Diretrizes para manutenção de múltiplos órgãos no 
potencial doador adulto falecido. Parte II. Ventilação mecânica, controle 
endócrino metabólico e aspectos hematológicos e infecciosos. Rev Bras 
Ter Intensiva. 2011;23(3):269-82.
 26. Westphal GA, Zaclikevis VR, Vieira KD, Cordeiro RB, Horner MB, Oliveira 
TP, et al. Protocolo gerenciado de tratamento do potencial doador falecido 
reduz incidência de parada cardíaca antes do explante dos órgãos. Rev 
Bras Ter Intensiva. 2012;24(4):334-40.
 27. Marik PE. Techniques for assessment of intravascular volume in critically ill 
patients. J Intensive Care Med. 2009;24(5):329-37.
 28. Olmos A, Swain S, Blasilbanez A, Cahilkova R, Feiner J, Niemann C. 
Hyperglycemia and perioperative renal injury in the setting of kidney 
transplantation: a quality assessment study [abstract]. In: 11th Congress of 
the International Society for Organ Donation and Procurement, 2nd Congress 
of the Iberoamerican Society of Transplant Coordinators; 2011Nov 27-30; 
Buenos Aires, Argentina. Buenos Aires: ISODP; 2011. p. 167.
 29. Blasi-Ibañez A, Hirose R, Feiner J, Freise C, Stock PG, Roberts JP, et al. 
Predictors associated with terminal renal function in deceased organ 
donors in the intensive care unit. Anesthesiology. 2009;110(2):333-41.
 30. Feng S. Donor intervention and organ preservation: where is the science 
and what are the obstacles? Am J Transplant. 2010;10(5):1155-62.
 31. Totsuka E, Fung U, Hakamada K, Tanaka M, Takahashi K, Nakai M, 
et al. Analysis of clinical variable of donors and recipients with respect to 
short-term graft outcome in human liver transplantation. Transplant Proc. 
2004;36(8):2215-8.
 32. Associação Brasileira de Transplante de Órgãos (ABTO). Diretrizes básicas 
para captação e retirada de múltiplos órgãos e tecidos da Associação 
Brasileira de Transplante de Órgãos. São Paulo: Associação Brasileira de 
Transplante de Órgãos; 2009.
 33. Moraes EL, Silva LB, Glezer M, Paixão NC, Moraes TC. Trauma e doação de 
órgãos e tecidos para transplante. J Bras Transpl. 2006;9:561-5.
 34. Thomson EM, McKeown DW. Organ donation and management of the 
potential organ donor. Anaesth Intensive Care Med. 2012;13(6):252-8.
